HS 3004 ยท All partner countries
Free charts show global trade totals and limited partner rankings. Select a country to carry it into product navigation and the CSV preview.
Showing all published months. Partner preview tables include up to 5 countries.
Codes with public product pages are linked.
Showing 24 of 47 official HS6 / HS8 child codes. Use the product explorer for published data pages.
Direct HS4 USD values by month. Exports and imports use separate scales.
Free partner previews show up to 5 countries.
Total value across the published data period
| Partner | Value | Share | |
|---|---|---|---|
| 1 | United States | $7.3B | 15.0% |
| 2 | Denmark | $5.6B | 11.6% |
| 3 | France | $3.9B | 8.1% |
| 4 | Australia | $2.8B | 5.8% |
| 5 | Italy | $2.1B | 4.4% |
Total value across the published data period
| Partner | Value | Share | |
|---|---|---|---|
| 1 | Germany | $42.3B | 22.0% |
| 2 | Italy | $20.0B | 10.4% |
| 3 | France | $16.2B | 8.4% |
| 4 | United States | $15.1B | 7.9% |
| 5 | Sweden | $12.9B | 6.7% |
Availability is confirmed when the API response loads.
Availability is confirmed when the API response loads.
Over the twelve months to August 2026, China's medicaments for therapeutic use trade under HS 3004 ran $8.5B of exports against $24.0B of imports, a trade deficit of $15.5B.
Monthly imports of medicaments for therapeutic use (HS 3004) ranged from $1.5B to $2.3B between September 2025 and August 2026, averaging $2.0B. The latest month, August 2026, came in at $1.5B, below the twelve-month average.
Exports over the same months came to $8.5B. Across the published period its largest destination markets are United States, Denmark and France.
Annual imports rose 27% between 2018 and 2025, from $18.1B to $23.1B.
The three largest source markets โ Germany, Italy and France โ account for 41% of the published total, out of 54 trading partners on record.
Sum of published monthly values per year. The latest year is labelled with its last published month until December is in.
| Year | Exports | Imports | Balance |
|---|---|---|---|
| 2018 | $3.9B | $18.1B | -$14.2B |
| 2019 | $3.8B | $21.2B | -$17.4B |
| 2020 | $4.3B | $21.2B | -$16.9B |
| 2021 | $5.3B | $23.5B | -$18.2B |
| 2022 | $5.8B | $22.5B | -$16.7B |
| 2023 | $5.6B | $24.1B | -$18.5B |
| 2024 | $6.2B | $22.5B | -$16.3B |
| 2025 | $8.0B | $23.1B | -$15.0B |
| 2026 (through Aug) | $5.4B | $15.9B | -$10.5B |
Free charts show this HS4 group. For a paid CSV, choose exact HS6 or HS8 products within the group in the order builder.
CSV orders from USD 9.90 ยท One-time purchase. Confirm available coverage and your total in the order preview before paying.
Download after payment. Large packages may need preparation; delivery timing is confirmed before checkout.
Need help choosing products or regular updates? Ask us for a quote by email.
HS 3004 is an official customs product-group classification. Monthly values are shown in USD, and long product names may be shortened for display.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments for therapeutic use Trade Data (HS 3004)." Accessed [date]. https://chinadata.live/china-trade/hs/3004/
China exported $8.5B of medicaments for therapeutic use in the twelve months to August 2026, averaging $705M per month, based on official China customs statistics (HS 3004).
United States, Denmark and France together account for 35% of the published total, out of 162 trading partners on record.
Annual exports grew by 103% between 2018 and 2025, from $3.9B to $8.0B.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available as a one-time CSV purchase. Choose your products and coverage, then preview the file and price before payment.